Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 728

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 6
Chunk 728
---
    Amendment
    to Employment Agreement between Mark Dybul, M.D. and the Company, dated December 12, 2022
     
    Incorporated
    herein by reference to Exhibit to 10.1 the Company’s Current Report on Form 8-K, filed with the SEC on December 16, 2022.

    10.10 
     
    Security
    Agreement, effective December 30, 2022, by and between the Company and Paseco ApS
     
    Incorporated
    herein by reference to Exhibit 10.2 to the Company’s Form 8-K filed with the SEC on February 23, 2023.

    10.11
     
    Purchase
    Agreement, dated June 20, 2023, by and between the Company and Lincoln Park Capital Fund, LLC
     
    Incorporated
    herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed with the SEC on June 27, 2023

    10.12
     
    Registration
    Rights Agreement, dated June 20, 2023, by and between the Company and Lincoln Park Capital Fund, LLC
     
    Incorporated
    herein by reference to Exhibit 10.2 to the Company’s Form 8-K filed with the SEC on June 27, 2023

    10.13
     
    Consulting
    Agreement, dated March 11, 2024, by and between Lunai Bioworks Inc. and Tarsh PB Advisors LLC.
     
    Incorporated
    herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed with the SEC on March 13, 2024

    10.14
     
    Form
    of Subscription Agreement
     
    Incorporated
    herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed with the SEC on August 7, 2023

    10.15
     
    Form
    of Subscription Agreement
     
    Incorporated
    herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed with the SEC on October 10, 2023

    10.16
     
    Form
    of Subscription Agreement
     
    Incorporated
    herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed with the SEC on June 21,